Molecular Basis of Cardiovascular Drug Metabolism
- 11 April 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (14) , 1749-1753
- https://doi.org/10.1161/01.cir.101.14.1749
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Diltiazem‐cyclosporin pharmacokinetic interaction — dose–response relationshipBritish Journal of Clinical Pharmacology, 1997
- Influence of itraconazole on the pharmacokinetics and electrocardiographic effects of astemizoleBritish Journal of Clinical Pharmacology, 1997
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- Unpredictability of Flecainide Plasma Concentrations in Patients with Renal FailureTherapeutic Drug Monitoring, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9Biochemical and Biophysical Research Communications, 1991
- Molecular genetics of the P-450 superfamilyPharmacology & Therapeutics, 1990
- PropafenoneNew England Journal of Medicine, 1990
- Reversal of drug resistance by erythromycin: Erythromycin increases the accumulation of actinomycin d and doxorubicin in multidrug‐resistant cellsInternational Journal of Cancer, 1989
- Clinical Importance of the Interaction of Diazepam and CimetidineNew England Journal of Medicine, 1984